Go to navigation
Go to content
Astrazeneca Worldwide
AstraZeneca Websites
Search
Main navigation
Home
Our medicines
Diseases and conditions
Community support
Help affording your medicines
Research & development
Healthcare professionals
Careers
About AstraZeneca US
Investors
Our company
AZ on the issues
Responsible business
Newsroom
Media resources
All news
Corporate news
Financial news
Product news
Research news
US web sites
Contact us
You are here
Home
About AstraZeneca US
Newsroom
Product news
The following shows headlines of all product-related news articles published within 12-months, starting from most recent.
Pages
1
2
3
Next
News search
Date
Nov 17, 2009
CRESTOR® reduced risk of cardiovascular events in women by nearly half in new analysis of JUPITER study
Nov 9, 2009
New post-hoc, pooled analysis shows SYMBICORT® improved airflow obstruction in patients with COPD
Oct 16, 2009
U.S. Food and Drug Administration approves CRESTOR® for use in pediatric patients with heterozygous familial hypercholesterolemia
Sep 25, 2009
US Court of Appeals affirms Summary Judgment decision in SEROQUEL® patent litigation
Sep 1, 2009
AstraZeneca encourages all Americans to get their cholesterol checked during National Cholesterol Education Month in September
Aug 31, 2009
CRESTOR® reduced risk of cardiovascular events in elderly patients in new analysis of JUPITER
Aug 14, 2009
ONGLYZA™ (saxagliptin), a new treatment for type 2 diabetes mellitus in adults, now available in U.S. pharmacies
Jul 31, 2009
U.S. Food and Drug Administration approves ONGLYZA™ (saxagliptin) for the treatment of type 2 diabetes mellitus in adults
Jun 10, 2009
Favorable vote from FDA Advisory Committee on SEROQUEL pediatric Supplemental New Drug Applications
Jun 4, 2009
AstraZeneca and Abbott extend relationship to include co-promotion of TRILIPIX® (fenofibric acid)
Pages
1
2
3
Next
Page tools
Print
Bookmark this page
Subscribe to RSS news feed
Follow us on Twitter
